Primary Site >> Stomach Cancer
Gene >> AXL
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. PMID: 10430078 |
Ref: Clinical significance of AXL kinase family in gastric cancer. PMID: 12168903 |
Ref: Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. PMID: 17186543 |
Ref: Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. PMID: 21655918 |
Ref: Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PMID: 23516391 Ref: Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion. PMID: 23536719 Ref: S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. PMID: 23804704 Ref: Molecular pathways: MERTK signaling in cancer. PMID: 23833304 |
Ref: High BIM mRNA levels are associated with longer survival in advanced gastric cancer. PMID: 28454330 Ref: MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines. PMID: 29285287 |